Last, it is worth noting that aberrant activity of KDM2B, which catalyzes the demethylation of H3K36me2, has also been observed in hematologic malignancies, further illustrating the critical significance of tight regulation of this modification for hematopoietic cell homeostasis. Here, KDM2B is linked to hematologic disorder.